Company profile
Bausch + Lomb Corporation
NYSE: BLCO · Healthcare · Medical - Instruments & Supplies
Canadian filerHQ Vaughan, ONCIK 0001860742Reports USD
#62 of 1,418 Healthcare companies by revenue51st-percentile growth
EA Score
67BFH 71DQ 60GM 67SS 66
v0.1 · 65/100 weight · provisional
↑ filing timeliness, workforce scale · ↓ listing tenure, disclosure history
Methodology →Revenue TTM
$5.2B
Rev growth YoY (TTM)
+7.8%
Net income (FY)
-$360.0M
Employees
13,000
as of 2026-08-07
Market cap
$5.8B
as of 2026-08-07
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$5.1B$5.1B2025
Net income-$360.0M-$360.0M2025
Operating income$113.0M$113.0M2025
Total assets$14.0B$14.0B2025
Liabilities$7.5B$7.5B2025
Equity$6.4B$6.4B2025
Revenue trend
FY2022 – FY2025 · USD
FY22
FY22
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Device Products38%
Over the Counter Products36%
Pharmaceutical Products21%
Branded and Other Generic Products5%
Other Revenues0%
By geography
United States and Puerto Rico53%
Other Countries16%
CHINA7%
FRANCE5%
JAPAN4%
GERMANY3%
The read
What is Bausch + Lomb Corporation’s revenue?
Bausch + Lomb Corporation booked $5.1B in FY2025 revenue, growing 6.5% year over year — about the middle of the pack among Healthcare companies we track, at a -7.1% net margin.
Peers · Healthcare
PACS Group, Inc.53DResMed Inc.88AIncyte Corporation90AThe Ensign Group, Inc.80B+Elanco Animal Health Incorporated66BDexCom, Inc.87AKey facts
CEOBrenton L. Saunders
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersVaughan, ON
ExchangeNYSE: BLCO
Employees13,000
IPO date2022-05-06
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.